Adam R Johnson
5PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 30, 2025
Discovery of Clinical Candidate GDC-8264, a Novel, Potent and Selective RIP1 Inhibitor for Amelioration of Tissue Damage and the Treatment of Inflammatory Diseases.Snahel Patel, Huifen Chen, Eugene Varfolomeev
|Mar 03, 2024
Discovery of TRPA1 Antagonist <b>GDC-6599</b>: Derisking Preclinical Toxicity and Aldehyde Oxidase Metabolism with a Potential First-in-Class Therapy for Respiratory Disease.Jack A Terrett, Justin Q Ly, Paula Katavolos
|May 19, 2019
RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases.Snahel Patel, Joshua D Webster, Eugene Varfolomeev
|Nov 23, 2018
Lung-restricted inhibition of Janus kinase 1 is effective in rodent models of asthma.Hart S Dengler, Xiumin Wu, Ivan Peng
|Jan 14, 2018
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus.Hans D Brightbill, Eric Suto, Nicole Blaquiere
Pageof 1
Frequent Collaborators
2 joint publications
Huifen Chen
2 joint publications
Snahel Patel
1 joint publications
Hart S Dengler
1 joint publications
Cornelia H Rinderknecht
1 joint publications
Eric Suto
1 joint publications
Julia Lloyd
1 joint publications
Mike Briggs
1 joint publications
Savita Ubhayakar
1 joint publications
Kevin Johnson
1 joint publications
Sheerin K Shahidi-Latham
